IP Library › Granted Patent US 12,226,125
Granted Patent B2
US 12,226,125 · App. 18/431,098 · Granted Feb 18, 2025

Autonomous vitrification in an intelligent automated in vitro fertilization and intracytoplasmic sperm injection platform

Inventors: Gerardo Mendizabal-Ruiz (Guadalajara, MX); Alejandro Chavez-Badiola (Mexico City, MX); Alan Murray (Greenwich, CT); Jacques Cohen (New York, NY); Adolfo Flores-Saiffe Farias (Zapopan, MX); Cesar Millan (Zapopan, MX); Roberto Valencia-Murillo (Las Paz, MX); Vladimir C. Ocegueda Hernandez (Zapopan, MX); Giuseppe Silvestri (Canterbury, GB); Nuno Costa-Borges (Barcelona, ES); José Gregorio Espinoza Figueroa (Zapopan, MX); Johann Aguayo (Guadalajara, MX); William Nicholas Garbarini, Jr. (Cranford, NJ)
Assignee: Conceivable Life Sciences Inc.
A61B17/43A61B34/32C12M21/06C12M33/04C12M41/48
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,125
App. No.
18/431,098
Granted
Feb 18, 2025
Kind
B2
Abstract

A method of artificial-intelligence-based robotic vitrification includes placing at least one oocyte in a buffer or CPA solution. The method includes processing an image object produced by an imaging system, using an AI/ML system, to determine a location of a retrievable target oocyte. The method includes positioning a robotic pipettor at a target physical orientation relative to the retrievable target oocyte. The method includes confirming the robotic pipettor's location at the target physical orientation, using the AI/ML system. The method includes instructing the robotic pipettor to initiate contact with the retrievable target oocyte and apply negative pressure to secure the oocyte to the robotic pipettor. The method includes using a robotic microtool holder to lower a vitrification assembly or cryo-device of any other make into a buffer or CPA solution dish to a position in proximity to the target physical orientation.

Claims (33)

1. A method of artificial-intelligence-based robotic vitrification, comprising:

receiving at least one tissue sample in a dish holding a first solution;

processing an image object produced by an imaging system, using an artificial intelligence/machine learning system (AI/ML system), to determine a location of a retrievable target tissue sample of the at least one tissue sample;

positioning a robotic pipettor at a target physical orientation relative to the retrievable target tissue sample;

confirming a position of the robotic pipettor at the target physical orientation using the AI/ML system;

instructing the robotic pipettor to initiate contact with the retrievable target tissue sample and apply negative pressure to secure the retrievable target tissue sample to the robotic pipettor;

using a robotic microtool holder to lower a cryo-device into the dish;

using the robotic pipettor to place the retrievable target tissue sample on the cryo-device in the dish;

using the AI/ML system to form a vitrification assembly by holding the robotic pipettor and the robotic microtool holder stationary relative to each other so that a relative physical placement of the retrievable target tissue sample and the cryo-device remains unchanged; and

moving, robotically, the vitrification assembly through a plurality of different solutions in an order commanded by the AI/ML system and for a specified length of time, creating a fluid bridge between a plurality of drops, until the vitrification assembly reaches a final drop of the plurality of drops, wherein the plurality of drops corresponds to the plurality of different solutions, and wherein a cryoprotective agent (CPA) concentration in the final drop exceeds a threshold concentration.

2. The method of claim 1 wherein each tissue sample of the at least one tissue sample is an embryo.

3. The method of claim 1 wherein each tissue sample of the at least one tissue sample is an oocyte.

4. The method of claim 1 wherein the image object is at least one of a still image, a time-lapse image, or a video image.

5. The method of claim 1 wherein a second quantity of negative pressure is applied via a motorized microinjector controlled at least in part by the AI/ML system.

6. The method of claim 1 wherein the robotic pipettor is a plurality of robotic pipettes.

7. The method of claim 1 wherein the target physical orientation is obtained based in part on rotating a stage on which the retrievable target tissue sample resides.

8. The method of claim 1 wherein the vitrification assembly includes a micro-mesh surface.

9. The method of claim 1 wherein the AI/ML system uses at least one neural network.

10. The method of claim 1 wherein the first solution is a buffer solution.

11. A method of artificial-intelligence-based robotic vitrification, the method comprising:

using an artificial intelligence system/machine learning system (AI/ML system) to issue an automated command to a robotic pipettor to obtain a tissue sample from a vessel;

guiding the robotic pipettor into a liquid containing a cryo-device held by a robotic microtool controlled at least in part by the AI/ML system;

positioning the robotic pipettor relative to the cryo-device to create a vitrification assembly, wherein the positioning is guided, using the AI/ML system, at least in part by analysis of at least one image object created by an imaging system; and

robotically altering a cryoprotectant concentration of the liquid in which the vitrification assembly holds the tissue sample, wherein the robotically altering includes exposing the tissue sample held by the vitrification assembly to increasing concentrations of cryoprotectant until the liquid reaches a threshold concentration of cryoprotectant.

12. The method of claim 11 wherein the tissue sample is an embryo.

13. The method of claim 11 wherein the tissue sample is an oocyte.

14. The method of claim 11 wherein the concentration of cryoprotectant is assessed automatically using the AI/ML system and the imaging system.

15. The method of claim 11 wherein the vitrification assembly includes a micro-mesh surface.

16. The method of claim 11 wherein exposing the tissue sample to increasing concentrations of cryoprotectant is automatically performed by the AI/ML system and robotic control of the vitrification assembly according to a predetermined rate of exposure.

17. The method of claim 11 wherein a rate associated with exposing the tissue sample to increasing concentrations of cryoprotectant is automatically determined in real-time by the AI/ML system based at least in part on an output of the imaging system.

18. The method of claim 11 wherein the at least one image object is a still image.

19. The method of claim 11 wherein the at least one image object is a video.

20. The method of claim 11 wherein the imaging system includes a microscopy system, a camera system, and a lighting system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2024
From: CHAVEZ-BADIOLA, ALEJANDRO; MURRAY, ALAN; COHEN, JACQUES; ABRAM, JOSHUA; MENDIZABAL-RUIZ, GERARDO; FLORES-SAIFFE FARIAS, ADOLFO; MILLAN, CESAR; VALENCIA-MURILLO, ROBERTO; OCEGUEDA HERNANDEZ, VLADIMIR C.; SILVESTRI, GIUSEPPE; COSTA-BORGES, NUNO; HERNANDEZ, ESTEFANIA; ALVAREZ, ANGEL; GREGORIO ESPINOZA FIGUEROA, JOSÉ; MANUEL RICO BOTERO, VICTOR; MANUEL MEDINA PEREZ, VICTOR; AGUAYO, JOHANN; GARBARINI, WILLIAM NICHOLAS, JR.; MARTÍNEZ, DAVID; PIZANO PARRA, ALEJANDRA; MURILLO, ANAIS LEROY; MAURICIO LÓPEZ GÓMEZ, CARLOS; ZAMARRIPA GONZALEZ, VALENTIN; ACOSTA GOMEZ, FATIMA J.; REYES LLAMAS, MARIO; KUKU, STEPHANIE
To: CONCEIVABLE LIFE SCIENCES INC.
Reel/Frame 068470/0904 →
Continuity (3)
Continuation PCTUS2024013428 · Jan 30, 2024
Provisional Application 63523258 · Jun 26, 2023
Related Publication 20240423672A1 · Dec 26, 2024
References Cited (20)
US 11494578B1 · Chian · 2022 [cited by applicant]
US 20130337487A1 · Loewke · 2013 [cited by applicant]
US 20140297199A1 · Osten · 2014 [cited by applicant]
US 20150252328A1 · Woodruff · 2015 [cited by applicant]
US 20170140535A1 · Hamamah · 2017 [cited by applicant]
US 20200305967A1 · Getman · 2020 [cited by examiner]
US 20220189640A1 · Wessels Wells · 2022 [cited by applicant]
US 20220358655A1 · Wessels Wells · 2022 [cited by applicant]
US 20230093989A1 · Mahajan · 2023 [cited by applicant]
US 20230303959A1 · Blanchard · 2023 [cited by examiner]
CN 112401994A · 2021 [cited by examiner]
WO 0004929A1 · 2000 [cited by applicant]
WO 2016001754A2 · 2016 [cited by applicant]
Zhu et al. “Study of Robotic System for Automated Oocyte Manipulation” (2017), IEEE, 2017 Intern'l Conf on Manipulation, Automation, and Robotics at Small Scales (MARSS). [cited by applicant]
Abdullah et al., “Automation in ART: Paving the Way for the Future of Infertility Treatment,” Published online Aug. 2022, Reproductive Sciences, vol. 30: 1006-1016. [cited by applicant]
Casciani et al., “Are we approaching automated assisted reproductive technology? Sperm analysis oocyte manipulation, and insemination,” Fertil Steril, vol. 2, No. 3: 189-203, 2021. [cited by applicant]
Trottmann, et al., “Ex vivo investigations on the potential of optical coherence tomography (OCT) as a diagnostic tool for reproductive medicine in a bovine model,” vol. 9, No. 1-2: 129-137, 2016. [cited by applicant]
Fan, et al., “Optimized Optical Coherence Tomography Imaging with Hough Transform-Based Fixed-Pattern Noise Reduction,” IEEE Access, vol. 6, 32087-32096, 2018. [cited by applicant]
Zhai, et al., “Automated Denudation of Oocytes,” Micromachines, 2022. [cited by applicant]
Targosz, et al., “Semantic segmentation of human oocyte images using deep neural networks,” BioMedical Engineering, 20:40, 2021. [cited by applicant]